Real-World Effectiveness of a Third Dose of mRNA-1273 versus BNT162b2 on Inpatient and Medically Attended COVID-19 among Immunocompromised Adults in the United States

Tianyu Sun, Linwei Li, Katherine Mues, Mihaela Georgieva, Brenna Kirk, James Mansi, Nicolas Van de Velde, Ekkehard Beck
doi: https://doi.org/10.1101/2024.01.30.24302015

Article usage

Article usage: February 2024 to June 2025

AbstractFullPdf
Feb 202446721237
Mar 2024982927
Apr 202459919
May 2024761513
Jun 2024601611
Jul 2024672331
Aug 2024681119
Sep 202467413
Oct 20244606
Nov 20241749
Dec 20242214
Jan 20252826
Feb 202521157
Mar 2025473621
Apr 2025261516
May 2025363117
Jun 20251024
Back to top
Posted January 31, 2024.
Download PDF
Data/Code
Email
Real-World Effectiveness of a Third Dose of mRNA-1273 versus BNT162b2 on Inpatient and Medically Attended COVID-19 among Immunocompromised Adults in the United States
Tianyu Sun, Linwei Li, Katherine Mues, Mihaela Georgieva, Brenna Kirk, James Mansi, Nicolas Van de Velde, Ekkehard Beck
medRxiv 2024.01.30.24302015; doi: https://doi.org/10.1101/2024.01.30.24302015
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area